126 - 150 of 274 Items

Review paper2023, nov 7

Obesity in perimenopause — current treatment options based on pathogenetic factors

Dominik Porada, Jakub Gołacki, Beata Matyjaszek-Matuszek

Vol 74, No 6 (2023)

Review paper

Pubmed: 37994584
Endokrynol Pol 2023;74(6):565-575.
Original paper2022, apr 5

Is thyroid autoimmunity associated with subclinical atherosclerosis in young women with type 1 diabetes mellitus?

Magdalena Maria Łukawska-Tatarczuk, Jakub Zieliński, Edward Franek, Leszek Czupryniak, Beata Mrozikiewicz-Rakowska

Vol 73, No 2 (2022)

Original paper

Pubmed: 35381091
Endokrynol Pol 2022;73(2):301-308.
Clinical vignette2023, feb 21

Liraglutide therapy in an adolescent with Prader‑Willi syndrome and concomitant diabetes mellitus

Ming Li, Nan Li, Zhufang Tian, Xiang Wang

Vol 74, No 2 (2023)

Clinical vignette

Pubmed: 36916545
Endokrynol Pol 2023;74(2):219-220.
Original paper2023, mar 10

MicroRNA-196a-5p targeting LRP1B modulates phenotype of thyroid carcinoma cells

Yaojie Hu, Chunying Zhang, Qing Chang, Jinghai Du, Haodong Lu, Xin Guo, Wang Chang, Shiguang Liu, Chunyou Chen

Vol 74, No 2 (2023)

Original paper

Pubmed: 36916542
Endokrynol Pol 2023;74(2):144-152.
Guidelines / Expert consensus2023, apr 28

Zalecenia postępowania diagnostycznego i leczniczego w osteoporozie w Polsce. Aktualizacja 2022

Piotr Głuszko, Ewa Sewerynek, Waldemar Misiorowski, Jerzy Konstantynowicz, Ewa Marcinowska-Suchowierska, Tomasz Blicharski, Mirosław Jabłoński, Edward Franek, Tomasz Kostka, Maciej Jaworski, Elżbieta Karczmarewicz, Ewa Kalinka, Krystyna Księżopolska-Orłowska, Andrzej Więcek, Roman S. Lorenc

Vol 74, Supp. A (2023)

Guidelines / Expert consensus

DOI: 10.5603/ep.94310
Clinical vignette2023, mar 24

Difficulties in the diagnosis and treatment of ruptured pheochromocytoma

Joanna Kokoszka, Ewelina Rzepka, Magdalena Ulatowska-Białas, Piotr Richter, Alicja Hubalewska-Dydejczyk

Vol 74, No 2 (2023)

Clinical vignette

Pubmed: 37039495
Endokrynol Pol 2023;74(2):211-212.
Guidelines / Expert consensus2023, oct 23

Management of hypoparathyroidism: a Position Statement of the Expert Group of the Polish Society of Endocrinology

Waldemar Misiorowski, Marek Dedecjus, Jerzy Konstantynowicz, Arkadiusz Zygmunt, Beata Kos-Kudła, Andrzej Lewiński, Marek Ruchała, Wojciech Zgliczyński

Vol 74, No 5 (2023)

Guidelines / Expert consensus

Pubmed: 37902011
Endokrynol Pol 2023;74(5):447-467.
Original paper2023, jun 21

Osteoporosis treatment with denosumab in routine clinical practice in Poland

Ewa Marcinowska-Suchowierska, Tomasz Blicharski, Ewa Wielosz, Maria Rell-Bakalarska, Krzysztof Duma, Katarzyna Paradowska-Kowal, Ewa Sewerynek

Vol 74, No 3 (2023)

Original paper

Pubmed: 37695033
Endokrynol Pol 2023;74(3):243-253.
Original paper2023, jun 12

Demographics, practice patterns, job satisfaction, and career plans of endocrinologists in Poland

Wojciech S. Zgliczyński, Adam Skowron

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335066
Endokrynol Pol 2023;74(3):331-339.
Original paper2023, may 2

The association between complement C1q tumour necrosis factor-related protein-1 (CTRP-1) level and metabolic syndrome

Guirong Bai, Xiaomin Xie, Huili Liu, Dan Qiang, Yanting He, Li Zhang, Xiaojuan Zhang

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155309
Endokrynol Pol 2023;74(3):271-276.
Original paper2023, jun 12

The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome

Anna Świąder-Leśniak, Dorota Jurkiewicz, Honorata Kołodziejczyk, Agata Kozłowska, Alicja Korpysz, Mieczysław Szalecki, Krystyna Chrzanowska

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335065
Endokrynol Pol 2023;74(3):285-293.
Original paper2023, may 15

Irisin attenuates pyroptosis in high glucose-induced pancreatic beta cells via the miR-133a-3p/FOXO1 axis

Anjun Tan, Tianrong Li, Jingjing Yang, Jinwen Yu, Hewen Chen

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335063
Endokrynol Pol 2023;74(3):277-284.
Original paper2023, jun 21

Bioinformatics analysis of CUL2/4A/9 and its function in head and neck squamous cell carcinoma

Bingqing Xu, Ruohuang Wang, Jisheng Zhang, Lin Wang, Xin Cui, Fangyu Chai, Xiaoyun Du, Yan Jiang

Vol 74, No 3 (2023)

Original paper

Pubmed: 37695034
Endokrynol Pol 2023;74(3):315-330.
Original paper2023, may 29
Original paper2023, may 8

MicroRNA-646 inhibits the proliferation of ovarian granulosa cells via insulin-like growth factor 1 (IGF-1) in polycystic ovarian syndrome (PCOS)

Jiali Lu, Feilan Xuan, Aixue Chen, Ruiying Jin, Weimei Zhou, Yongju Ye, Yuefang Ren

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155307
Endokrynol Pol 2023;74(3):305-314.
Original paper2023, may 2

The impact of subclinical hypothyroidism on growth and development in infants and young children aged 0 to 5 years

Xueqin Yan, Guomei Jiang, Chunhui Yang, Yuming Chen, Jie Zeng, Lianhong Huang, Xia Chen, Jialuo Liao

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155310
Endokrynol Pol 2023;74(3):254-259.
Original paper2023, may 4

Leukocyte transcriptome of Cushing’s disease are associated with nerve impairment and psychiatric disorders

Kunyu He, Tao Zhou, Fuyu Wang, Fangye Li, Yanyang Zhang, Xinguang Yu

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155308
Endokrynol Pol 2023;74(3):294-304.
Clinical vignette2023, jun 12

COVID-19 infection in a patient with Cushing’s disease on osilodrostat treatment

Anna Bogusławska, Mari Minasyan, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37335068
Endokrynol Pol 2023;74(3):342-343.
Guidelines / Expert consensus2024, aug 19

Polish diagnostic and therapeutic recommendations for adrenocortical carcinoma

Daria Handkiewicz-Junak, Marek Dedecjus, Urszula Ambroziak, Marcin Barczyński, Lucyna Bednarek-Papierska, Ewa Chmielik, Andrzej Cichocki, Agnieszka Czarniecka, Jarosław Ćwikła, Kornelia Hasse-Lazar, Alicja Hubalewska-Dydejczyk, Joanna Januszkiewicz-Caulier, Barbara Jarząb, Grzegorz Kamiński, Małgorzata Karbownik-Lewińska, Agnieszka Kolasińska-Ćwikła, Łukasz Koperski, Beata Kos-Kudła, Agnieszka Kotecka-Blicharz, Aldona Kowalska, Jolanta Krajewska, Leszek Królicki, Andrzej Lewiński, Iwona Michałowska, Małgorzata Oczko-Wojciechowska, Marek Ruchała, Anhelli Syrenicz, Andrzej Tysarowski, Barbara Ziółkowska, Agnieszka Żyłka

Vol 75, No 4 (2024)

Guidelines / Expert consensus

Pubmed: 39279304
Endokrynol Pol 2024;75(4):339-358.
Review paper2023, oct 27

Mitophagy in tumor: foe or friend?

Li Li, Fei Hu

Vol 74, No 5 (2023)

Review paper

Pubmed: 37902014
Endokrynol Pol 2023;74(5):511-519.
Review paper2023, aug 17

The antifracture efficacy of vitamin D in adults — are we assessing it reliably? A systematic review

Jerzy Przedlacki, Urszula Ołdakowska-Jedynak

Vol 74, No 5 (2023)

Review paper

Pubmed: 37779375
Endokrynol Pol 2023;74(5):499-510.
Review paper2023, aug 17
Clinical vignette2023, jun 21

Progression of a corticotroph tumour during durable medical therapy with osilodrostat in a patient with persistent Cushing’s disease

Bartłomiej Borawski, Agnieszka Wojciechowska-Luźniak, Grzegorz Zieliński, Przemysław Witek

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37695035
Endokrynol Pol 2023;74(3):346-347.
Clinical vignette2023, may 8

Adverse outcome of T3-predominant maternal Grave’s disease during pregnancy in the mother and the offspring

Aleksandra Mikołajczak, Renata Bokiniec, Agnieszka Sienicka, Agata Pisula, Ewa Romejko-Wolniewicz

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37155306
Endokrynol Pol 2023;74(3):340-341.
Clinical vignette2023, may 8

Ectopic parathyroid adenoma in a patient with multiple endocrine tumours

Inês Lemos Damásio, Inês Patrocínio Carvalho, Sara de Miranda Lemos Donato Bento, Valeriano Alberto Pais Horta Leite

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37155305
Endokrynol Pol 2023;74(3):344-345.